{
    "SPADE_UN_22308": {
        "Sequence Information": {
            "Peptide Name": "LP-86",
            "Sequence": "LEANIEELLKKAEEQQKKNEEELKKLEKC",
            "Sequence Length": 29,
            "Biological Activity": [
                "Antiviral"
            ],
            "Binding Target": "1. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P03377",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P03377",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors With Extremely Potent and Long-Lasting Antiviral Activity.",
                    "Pubmed ID": "30867304",
                    "Reference": "J Virol. 2019;93:e02312-18",
                    "Author": "Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30867304"
                }
            ],
            "Mass": 3485.96,
            "PI": 5.0,
            "Net Charge": -2,
            "Hydrophobicity": -1.49,
            "Frequent Amino Acids": "EKL",
            "Absent Amino Acids": "DFGHMOPRSTUVWY",
            "Basic Residues": 7,
            "Acidic Residues": 9,
            "Hydrophobic Residues": 9,
            "Polar Residues": 20,
            "Positive Residues": 7,
            "Negative Residues": 9,
            "SPADE ID": "SPADE_UN_22308",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14344",
                    "Similarity": 1.0,
                    "Sequence": "VRYLEANIEELLKKAEEQQKKNEEELKKLE"
                },
                {
                    "SPADE_ID": "SPADE_UN_14353",
                    "Similarity": 1.0,
                    "Sequence": "LEANIEELLKKAEEQQKKNEEELKKLEK"
                },
                {
                    "SPADE_ID": "SPADE_UN_14368",
                    "Similarity": 1.0,
                    "Sequence": "VRYLEANIEELLKKAEEQQKKNEEELKKLEK"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1 NL4-3(IC50 I=0.00000043µM),HIV-1 JRCSF(IC50 I=0.00000478µM),HIV-1 PsV(IC50 I=0.00000491µM),HIV-1 NL4-3 D36G(IC50 I=0.000003µM),HIV-1 NL4-3(IC50 I=0.000003µM),HIV-1 NL4-3(IC50 I=0.000004-0.00017µM),HIV-2 ROD(IC50 I=0.000026µM),HIV-2(IC50 I=0.000014µM),HIV-1(IC50 F=0.00001227µM),Simian immunodeficiency virus (SIV)(IC50 I=0.000005-0.000006µM)"
        }
    }
}